\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\\ bilateral\\ hip\\ pain\\ upon\\ standing\\ and\\ walking\\.\\ pt\\ is\\ ttp\\ along\\ hip\\ joints\\ bilaterally\\.\\ pt\\ has\\ longstanding\\ pain\\ with\\ worsening\\ in\\ his\\ hip\\ pain\\ recently\\.\ \(0\)\
\-\ treatment\\ options\\ for\\ avascular\\ necrosis\\ of\\ the\\ femoral\\ heads\\ include\\ conservative\\ management\\,\\ total\\ hip\\ replacement\\,\\ core\\ decomprssion\\ with\\ or\\ without\\ bone\\ grafting\\ and\\ osteotomy\\.\\ \\ \ \(0\)\
\-\ this\\ patient\\ received\\ a\\ total\\ right\\ hip\\ arthroplasty\\ with\\ potential\\ replacement\\ of\\ left\\ hip\\ in\\ future\\.\ \(0\)\
\-\ frontal\\ and\\ frog\\ leg\\ films\\ of\\ both\\ hip\\ joints\\ revealed\\ extensive\\ degenerative\\ changes\\ on\\ the\\ bilateral\\ femoral\\ heads\\ and\\ acetabula\\.\\ acetabula\\ demonstrate\\ sclerosis\\ and\\ associated\\ osteophyte\\ and\\ subchondral\\ cyst\\ formation\\.\\ the\\ bilateral\\ femoral\\ heads\\ demonstrate\\ extensive\\ osteoarthritic\\ changes\\ with\\ sclerosis\\,\\ cyst\\ formation\\,\\ bilateral\\ ring\\ osteophytes\\ and\\ some\\ mild\\ flattening\\ of\\ the\\ femoral\\ heads\\.\\ \ \(0\)\
\-\ coronal\\ t1\\ and\\ t2\\ mri\\:\\ t1\\ and\\ t2\\ mri\\ revealed\\ extensive\\ degenerative\\ changes\\ on\\ the\\ bilateral\\ femoral\\ heads\\ and\\ acetabula\\.\\ there\\ is\\ high\\ signal\\ intensity\\ degenerative\\ edema\\ of\\ the\\ femoral\\ heads\\ on\\ t2\\.\\ superior\\ acetabula\\ demonstrate\\ low\\ signal\\ intensity\\ on\\ t1\\ and\\ associated\\ osteophyte\\ and\\ subchondral\\ cyst\\ formation\\.\\ the\\ bilateral\\ femoral\\ heads\\ demonstrate\\ extensive\\ osteoarthritic\\ changes\\ with\\ sclerosis\\,\\ cyst\\ formation\\,\\ bilateral\\ ring\\ osteophytes\\ and\\ some\\ mild\\ flattening\\ of\\ the\\ femoral\\ heads\\.\\ there\\ are\\ small\\ areas\\ of\\ abnormal\\ signal\\ to\\ suggest\\ avascular\\ necrosis\\.\ \(0\)\
\-\ avascular\\ necrosis\\ of\\ femoral\\ heads\\ bilaterally\\ with\\ associated\\ osteoarthritic\\ changes\\.\ \(0\)\
\-\ secondary\\ osteoarthritis\\ from\\ avascular\\ necrosis\ \(0\)\
\-\ primary\\ osteoarthritis\ \(4\)\
\-\ patient\\ is\\ a\\ 49\\ year\\ old\\ african\\ american\\ male\\ with\\ a\\ history\\ of\\ sarcoidosis\\,\\ sinusitis\\ with\\ intermittent\\ steroid\\ treatment\\ that\\ presents\\ with\\ several\\ years\\ of\\ bilateral\\ hip\\ pain\\.\ \(0\)\
\-\ avn\\ most\\ often\\ occurs\\ during\\ the\\ fourth\\ or\\ fifth\\ decade\\ of\\ life\\ and\\ is\\ bilateral\\ in\\ 55\\%\\ of\\ cases\\.\\ \\ the\\ etiology\\ for\\ avn\\ of\\ the\\ femoral\\ heads\\ is\\ vast\\ and\\ includes\\ trauma\\,\\ hemoglobinopathies\\,\\ caisson\\ disease\\,\\ local\\ infiltrative\\ diseases\\ such\\ as\\ gaucher\\ disease\\,\\ hypercortisolism\\,\\ alcohol\\,\\ pancreatitis\\,\\ renal\\ failure\\,\\ cigarteet\\ smoking\\,\\ collagen\\ vascular\\ diseasese\\,\\ congenital\\ diseases\\ such\\ as\\ scfe\\ and\\ legg\\-calvep\\-perthe\\,\\ fabry\\,\\ giant\\ cell\\ arteritis\\,\\ gout\\,\\ hemodialysis\\,\\ hld\\,\\ hyperparathyroidism\\,\\ pregnancy\\,\\ sle\\,\\ and\\ idiopathic\\.\\ the\\ most\\ common\\ cause\\ of\\ bilateral\\ avn\\ is\\ steroid\\ use\\,\\ even\\ for\\ short\\ periods\\.\\ our\\ patient\\ had\\ a\\ history\\ of\\ stage\\ i\\ sarcoid\\ disease\\ that\\ was\\ untreated\\.\\ \\ the\\ etiology\\ of\\ this\\ patient\\'s\\ bilateral\\ avn\\ of\\ the\\ femoral\\ head\\ is\\ unclear\\.\\ \\ there\\ is\\ no\\ case\\ report\\ of\\ a\\ link\\ between\\ sarcoid\\ and\\ avn\\.\\ the\\ patient\\ did\\ however\\ have\\ chronic\\ recurrent\\ bouts\\ of\\ sinusitis\\ that\\ required\\ steroids\\.\\ \\ he\\ received\\ both\\ fluticasone\\ and\\ oral\\ prednisone\\ for\\ short\\ periods\\ during\\ these\\ recurrent\\ attacks\\ of\\ sinusitis\\.\\ \\ this\\ appears\\ to\\ be\\ one\\ possible\\ etiology\\ of\\ his\\ avn\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ heads\\:\\ 0\\.40877226224675806\ \(0\)\
\-\ femoral\\:\\ 0\\.30987553844736354\ \(0\)\
\-\ avn\\:\\ 0\\.2718874265557042\ \(0\)\
\-\ hip\\:\\ 0\\.23292417091288112\ \(0\)\
\-\ bilateral\\:\\ 0\\.2240706909701853\ \(0\)\
\-\ acetabula\\:\\ 0\\.20248079522924342\ \(0\)\
\-\ of\\:\\ 0\\.1557633158312574\ \(0\)\
\-\ avascular\\:\\ 0\\.15076294771927756\ \(0\)\
\-\ and\\:\\ 0\\.148808646343624\ \(0\)\
\-\ osteoarthritic\\:\\ 0\\.13696615724014408\ \(0\)\
\-\ formation\\:\\ 0\\.12019405337182555\ \(0\)\
\-\ sinusitis\\:\\ 0\\.11728429561608358\ \(0\)\
\-\ extensive\\:\\ 0\\.11681256591253893\ \(0\)\
\-\ necrosis\\:\\ 0\\.11588803039477985\ \(0\)\
\-\ changes\\:\\ 0\\.11453266889607153\ \(0\)\
\-\ the\\:\\ 0\\.11344305610841007\ \(0\)\
\-\ degenerative\\:\\ 0\\.09659378946751286\ \(0\)\
\-\ periods\\:\\ 0\\.0927888331702808\ \(0\)\
\-\ etiology\\:\\ 0\\.09159965338099516\ \(0\)\
\-\ cyst\\:\\ 0\\.08745762043610615\ \(0\)\
\-\ osteophyte\\:\\ 0\\.0843833306717221\ \(0\)\
\-\ is\\:\\ 0\\.0830382891266583\ \(0\)\
\-\ sclerosis\\:\\ 0\\.08099082284391232\ \(0\)\
\-\ osteophytes\\:\\ 0\\.0807696421267939\ \(0\)\
\-\ demonstrate\\:\\ 0\\.07881729773130418\ \(0\)\
\-\ flattening\\:\\ 0\\.0747632759752363\ \(0\)\
\-\ steroid\\:\\ 0\\.07306451644678566\ \(0\)\
\-\ subchondral\\:\\ 0\\.07254331795694834\ \(0\)\
\-\ sarcoid\\:\\ 0\\.07109218406652092\ \(0\)\
\-\ t1\\:\\ 0\\.07084639340971156\ \(0\)\
\-\ diseases\\:\\ 0\\.06964631830621329\ \(0\)\
\-\ osteoarthritis\\:\\ 0\\.0692415502215375\ \(0\)\
\-\ replacement\\:\\ 0\\.06809634704884254\ \(0\)\
\-\ with\\:\\ 0\\.06679559330372153\ \(0\)\
\-\ received\\:\\ 0\\.06596106168691554\ \(0\)\
\-\ t2\\:\\ 0\\.06541861607576498\ \(0\)\
\-\ joints\\:\\ 0\\.06515542969307093\ \(0\)\
\-\ short\\:\\ 0\\.06515542969307093\ \(0\)\
\-\ signal\\:\\ 0\\.06445710804107549\ \(0\)\
\-\ ring\\:\\ 0\\.06385338195438237\ \(0\)\
\-\ total\\:\\ 0\\.062112165974312586\ \(0\)\
\-\ patient\\:\\ 0\\.061638480922079526\ \(0\)\
\-\ recurrent\\:\\ 0\\.06078217110008038\ \(0\)\
\-\ decomprssion\\:\\ 0\\.06061393432066762\ \(0\)\
\-\ cigarteet\\:\\ 0\\.06061393432066762\ \(0\)\
\-\ diseasese\\:\\ 0\\.06061393432066762\ \(0\)\
\-\ associated\\:\\ 0\\.0599319694761063\ \(0\)\
\-\ hypercortisolism\\:\\ 0\\.05791985018709006\ \(0\)\
\-\ fluticasone\\:\\ 0\\.05600836707446597\ \(0\)\
\-\ pt\\:\\ 0\\.05455394907696261\ \(0\)\
\-\ hemoglobinopathies\\:\\ 0\\.05452570558502065\ \(0\)\
\-\ pain\\:\\ 0\\.05425126638788419\ \(0\)\
\-\ intensity\\:\\ 0\\.053826196919538785\ \(0\)\
\-\ fabry\\:\\ 0\\.05331428294088841\ \(0\)\
\-\ bilaterally\\:\\ 0\\.05055612693351254\ \(0\)\
\-\ caisson\\:\\ 0\\.049920138338819\ \(0\)\
\-\ hld\\:\\ 0\\.049920138338819\ \(0\)\
\-\ bouts\\:\\ 0\\.049920138338819\ \(0\)\
\-\ revealed\\:\\ 0\\.04970459210282367\ \(0\)\
\-\ that\\:\\ 0\\.049344453293337295\ \(0\)\
\-\ such\\:\\ 0\\.04876130608064454\ \(0\)\
\-\ attacks\\:\\ 0\\.04870871569468677\ \(0\)\
\-\ osteotomy\\:\\ 0\\.048176877604455014\ \(0\)\
\-\ hemodialysis\\:\\ 0\\.048176877604455014\ \(0\)\
\-\ during\\:\\ 0\\.048014389076197615\ \(0\)\
\-\ disease\\:\\ 0\\.04773004255349505\ \(0\)\
\-\ some\\:\\ 0\\.04769544117283469\ \(0\)\
\-\ frog\\:\\ 0\\.047226054205241445\ \(0\)\
\-\ gaucher\\:\\ 0\\.0463944165851404\ \(0\)\
\-\ his\\:\\ 0\\.045973590660202006\ \(0\)\
\-\ for\\:\\ 0\\.04595151314988689\ \(0\)\
\-\ on\\:\\ 0\\.0457885091669594\ \(0\)\
\-\ vast\\:\\ 0\\.0456553857467147\ \(0\)\
\-\ scfe\\:\\ 0\\.04531457109261736\ \(0\)\
\-\ there\\:\\ 0\\.04524355191242769\ \(0\)\
\-\ arthroplasty\\:\\ 0\\.044990388309598596\ \(0\)\
\-\ longstanding\\:\\ 0\\.04410314844848513\ \(0\)\
\-\ grafting\\:\\ 0\\.043831909603172035\ \(0\)\
\-\ arteritis\\:\\ 0\\.043831909603172035\ \(0\)\
\-\ untreated\\:\\ 0\\.043831909603172035\ \(0\)\
\-\ mild\\:\\ 0\\.04297140536071699\ \(0\)\
\-\ unclear\\:\\ 0\\.0426204869590398\ \(0\)\
\-\ both\\:\\ 0\\.042272302206410706\ \(0\)\
\-\ link\\:\\ 0\\.04087722622467581\ \(0\)\
\-\ sle\\:\\ 0\\.04022847434339489\ \(0\)\
\-\ decade\\:\\ 0\\.03992640282546224\ \(0\)\
\-\ prednisone\\:\\ 0\\.03992640282546224\ \(0\)\
\-\ most\\:\\ 0\\.039450947653788954\ \(0\)\
\-\ this\\:\\ 0\\.03907167746809137\ \(0\)\
\-\ mri\\:\\ 0\\.03891129467526886\ \(0\)\
\-\ infiltrative\\:\\ 0\\.03883917873248457\ \(0\)\
\-\ ttp\\:\\ 0\\.03859306063175038\ \(0\)\
\-\ collagen\\:\\ 0\\.03847333795077287\ \(0\)\
\-\ gout\\:\\ 0\\.038240176166838016\ \(0\)\
\-\ core\\:\\ 0\\.03801491971283816\ \(0\)\
\-\ future\\:\\ 0\\.03801491971283816\ \(0\)\
\-\ fifth\\:\\ 0\\.03769073692981939\ \(0\)\
\-\ pancreatitis\\:\\ 0\\.03758609808965941\ \(0\)\
\-\ treatment\\:\\ 0\\.036109696864556944\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.036103436600214076\ \(0\)\
\-\ 49\\:\\ 0\\.03577925381719531\ \(0\)\
\-\ walking\\:\\ 0\\.03562290709719325\ \(0\)\
\-\ standing\\:\\ 0\\.03524741572696354\ \(0\)\
\-\ smoking\\:\\ 0\\.03510296592871924\ \(0\)\
\-\ alcohol\\:\\ 0\\.0350319018392643\ \(0\)\
\-\ african\\:\\ 0\\.03423361148628293\ \(0\)\
\-\ options\\:\\ 0\\.03417122202295045\ \(0\)\
\-\ fourth\\:\\ 0\\.03398749338554874\ \(0\)\
\-\ potential\\:\\ 0\\.033867770704571226\ \(0\)\
\-\ giant\\:\\ 0\\.033808708724336375\ \(0\)\
\-\ our\\:\\ 0\\.0335775748448966\ \(0\)\
\-\ steroids\\:\\ 0\\.03329952469296286\ \(0\)\
\-\ recently\\:\\ 0\\.03308516968361775\ \(0\)\
\-\ local\\:\\ 0\\.03262675144568304\ \(0\)\
\-\ 55\\:\\ 0\\.03257771484653547\ \(0\)\
\-\ american\\:\\ 0\\.03233781770568674\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.03210628107255528\ \(0\)\
\-\ idiopathic\\:\\ 0\\.032060926432107124\ \(0\)\
\-\ report\\:\\ 0\\.03192669097719118\ \(0\)\
\-\ even\\:\\ 0\\.031882541784682944\ \(0\)\
\-\ life\\:\\ 0\\.03109505335709014\ \(0\)\
\-\ pregnancy\\:\\ 0\\.031017339850991605\ \(0\)\
\-\ intermittent\\:\\ 0\\.030978821313979398\ \(0\)\
\-\ suggest\\:\\ 0\\.030789508535875792\ \(0\)\
\-\ as\\:\\ 0\\.03045335055819229\ \(0\)\
\-\ oral\\:\\ 0\\.030356022518664445\ \(0\)\
\-\ coronal\\:\\ 0\\.03018343024282719\ \(0\)\
\-\ stage\\:\\ 0\\.03018343024282719\ \(0\)\
\-\ films\\:\\ 0\\.030015207864567107\ \(0\)\
\-\ occurs\\:\\ 0\\.02988363071295791\ \(0\)\
\-\ upon\\:\\ 0\\.029818806500962573\ \(0\)\
\-\ includes\\:\\ 0\\.02947315543100698\ \(0\)\
\-\ conservative\\:\\ 0\\.029262203458369586\ \(0\)\
\-\ use\\:\\ 0\\.02900046344101674\ \(0\)\
\-\ history\\:\\ 0\\.028961700318834546\ \(0\)\
\-\ worsening\\:\\ 0\\.028943673103617326\ \(0\)\
\-\ failure\\:\\ 0\\.028776157617110297\ \(0\)\
\-\ leg\\:\\ 0\\.028612761784300448\ \(0\)\
\-\ in\\:\\ 0\\.02828654225394416\ \(0\)\
\-\ management\\:\\ 0\\.027996620663089868\ \(0\)\
\-\ appears\\:\\ 0\\.027755854139819215\ \(0\)\
\-\ congenital\\:\\ 0\\.027233116761908132\ \(0\)\
\-\ did\\:\\ 0\\.027189546579380344\ \(0\)\
\-\ required\\:\\ 0\\.027060524486070884\ \(0\)\
\-\ or\\:\\ 0\\.026371029318891476\ \(0\)\
\-\ cause\\:\\ 0\\.025820767346861017\ \(0\)\
\-\ areas\\:\\ 0\\.02573299289966119\ \(0\)\
\-\ possible\\:\\ 0\\.025680879463678565\ \(0\)\
\-\ cases\\:\\ 0\\.0254932194439797\ \(0\)\
\-\ along\\:\\ 0\\.02539305027509809\ \(0\)\
\-\ vascular\\:\\ 0\\.025022476993879644\ \(0\)\
\-\ several\\:\\ 0\\.024867588184805337\ \(0\)\
\-\ often\\:\\ 0\\.024731209711316853\ \(0\)\
\-\ superior\\:\\ 0\\.024641821425592177\ \(0\)\
\-\ between\\:\\ 0\\.024627039597411984\ \(0\)\
\-\ frontal\\:\\ 0\\.024394896194815097\ \(0\)\
\-\ renal\\:\\ 0\\.023602796345901365\ \(0\)\
\-\ primary\\:\\ 0\\.023305789179606094\ \(0\)\
\-\ years\\:\\ 0\\.023233566413885846\ \(0\)\
\-\ abnormal\\:\\ 0\\.022771158725800315\ \(0\)\
\-\ edema\\:\\ 0\\.022605728711114246\ \(0\)\
\-\ head\\:\\ 0\\.022605728711114246\ \(0\)\
\-\ include\\:\\ 0\\.022551488172950447\ \(0\)\
\-\ chronic\\:\\ 0\\.022497686834246546\ \(0\)\
\-\ secondary\\:\\ 0\\.02246561390458597\ \(0\)\
\-\ he\\:\\ 0\\.022444317639474805\ \(0\)\
\-\ however\\:\\ 0\\.02243369504884045\ \(0\)\
\-\ trauma\\:\\ 0\\.02201217463205965\ \(0\)\
\-\ low\\:\\ 0\\.021748510966919907\ \(0\)\
\-\ one\\:\\ 0\\.021700812061237536\ \(0\)\
\-\ cell\\:\\ 0\\.021681827965390105\ \(0\)\
\-\ high\\:\\ 0\\.021541150254090632\ \(0\)\
\-\ common\\:\\ 0\\.021494911869672756\ \(0\)\
\-\ these\\:\\ 0\\.021403389361666025\ \(0\)\
\-\ bone\\:\\ 0\\.02068064389665415\ \(0\)\
\-\ physical\\:\\ 0\\.020551465023008753\ \(0\)\
\-\ without\\:\\ 0\\.019992006985731448\ \(0\)\
\-\ small\\:\\ 0\\.01955125228241694\ \(0\)\
\-\ exam\\:\\ 0\\.019080006957435638\ \(0\)\
\-\ case\\:\\ 0\\.0190416736067273\ \(0\)\
\-\ to\\:\\ 0\\.018950971478330303\ \(0\)\
\-\ have\\:\\ 0\\.018934248258232672\ \(0\)\
\-\ had\\:\\ 0\\.01888428990989495\ \(0\)\
\-\ presents\\:\\ 0\\.01823293424214224\ \(0\)\
\-\ has\\:\\ 0\\.017312639201528795\ \(0\)\
\-\ male\\:\\ 0\\.016875535621562916\ \(0\)\
\-\ be\\:\\ 0\\.015375423828147878\ \(0\)\
\-\ from\\:\\ 0\\.01505316314266371\ \(0\)\
\-\ are\\:\\ 0\\.014382176585610902\ \(0\)\
\-\ was\\:\\ 0\\.01320930615541998\ \(0\)\
\-\ left\\:\\ 0\\.01292928097201939\ \(0\)\
\-\ right\\:\\ 0\\.01256616104961322\ \(0\)\
\-\ no\\:\\ 0\\.01232537741662878\ \(0\)\
\-\ year\\:\\ 0\\.011680724371565667\ \(0\)\
\-\ old\\:\\ 0\\.011217538779787178\ \(0\)\
